JPH07242555A - Glucosyl transferase-inhibiting agent and dental caries-resistant agent and dental caries-resistant food containing the same as active ingredient - Google Patents
Glucosyl transferase-inhibiting agent and dental caries-resistant agent and dental caries-resistant food containing the same as active ingredientInfo
- Publication number
- JPH07242555A JPH07242555A JP6062137A JP6213794A JPH07242555A JP H07242555 A JPH07242555 A JP H07242555A JP 6062137 A JP6062137 A JP 6062137A JP 6213794 A JP6213794 A JP 6213794A JP H07242555 A JPH07242555 A JP H07242555A
- Authority
- JP
- Japan
- Prior art keywords
- bark
- tree
- tannin
- dental caries
- active ingredient
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 230000002401 inhibitory effect Effects 0.000 title claims abstract description 20
- 239000004480 active ingredient Substances 0.000 title claims abstract description 11
- 102000000340 Glucosyltransferases Human genes 0.000 title claims description 21
- 108010055629 Glucosyltransferases Proteins 0.000 title claims description 21
- 235000013305 food Nutrition 0.000 title claims description 13
- 208000002925 dental caries Diseases 0.000 title abstract description 13
- 229920002770 condensed tannin Polymers 0.000 claims abstract description 17
- 239000000284 extract Substances 0.000 claims abstract description 14
- 239000003795 chemical substances by application Substances 0.000 claims abstract description 12
- 238000004440 column chromatography Methods 0.000 claims abstract description 4
- 238000001179 sorption measurement Methods 0.000 claims abstract description 4
- 235000013373 food additive Nutrition 0.000 claims abstract 2
- 239000002778 food additive Substances 0.000 claims abstract 2
- 239000004075 cariostatic agent Substances 0.000 claims description 19
- 238000004519 manufacturing process Methods 0.000 claims description 11
- 229940122959 Glucosyltransferase inhibitor Drugs 0.000 claims description 8
- 238000006116 polymerization reaction Methods 0.000 claims description 7
- 238000000638 solvent extraction Methods 0.000 claims description 2
- 230000000170 anti-cariogenic effect Effects 0.000 claims 2
- 229920001864 tannin Polymers 0.000 abstract description 37
- 239000001648 tannin Substances 0.000 abstract description 37
- 235000018553 tannin Nutrition 0.000 abstract description 37
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 abstract description 33
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 abstract description 30
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract description 11
- 235000010643 Leucaena leucocephala Nutrition 0.000 abstract description 7
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 abstract description 6
- 239000002904 solvent Substances 0.000 abstract description 5
- 230000015572 biosynthetic process Effects 0.000 abstract description 3
- 241000218641 Pinaceae Species 0.000 abstract description 2
- 235000011613 Pinus brutia Nutrition 0.000 abstract description 2
- 230000001580 bacterial effect Effects 0.000 abstract description 2
- 241000220479 Acacia Species 0.000 abstract 1
- 241000220485 Fabaceae Species 0.000 abstract 1
- 241000534018 Larix kaempferi Species 0.000 abstract 1
- 125000002791 glucosyl group Chemical group C1([C@H](O)[C@@H](O)[C@H](O)[C@H](O1)CO)* 0.000 abstract 1
- 210000000214 mouth Anatomy 0.000 abstract 1
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 27
- 238000010828 elution Methods 0.000 description 17
- 235000019441 ethanol Nutrition 0.000 description 11
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 9
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 8
- 230000000675 anti-caries Effects 0.000 description 8
- 239000000203 mixture Substances 0.000 description 7
- 210000000051 wattle Anatomy 0.000 description 7
- 240000007472 Leucaena leucocephala Species 0.000 description 6
- 241000194019 Streptococcus mutans Species 0.000 description 6
- 229930006000 Sucrose Natural products 0.000 description 6
- -1 castella Substances 0.000 description 6
- 230000007505 plaque formation Effects 0.000 description 6
- 239000000047 product Substances 0.000 description 6
- 239000005720 sucrose Substances 0.000 description 6
- 241000218652 Larix Species 0.000 description 5
- 235000005590 Larix decidua Nutrition 0.000 description 5
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 5
- 235000014113 dietary fatty acids Nutrition 0.000 description 5
- 238000000605 extraction Methods 0.000 description 5
- 239000000194 fatty acid Substances 0.000 description 5
- 229930195729 fatty acid Natural products 0.000 description 5
- 235000011187 glycerol Nutrition 0.000 description 5
- 239000000126 substance Substances 0.000 description 5
- 238000012360 testing method Methods 0.000 description 5
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 4
- 229920001503 Glucan Polymers 0.000 description 4
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 4
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 4
- 244000005700 microbiome Species 0.000 description 4
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 3
- 208000002064 Dental Plaque Diseases 0.000 description 3
- 102000004190 Enzymes Human genes 0.000 description 3
- 108090000790 Enzymes Proteins 0.000 description 3
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 3
- DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 description 3
- UEDUENGHJMELGK-HYDKPPNVSA-N Stevioside Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@]12C(=C)C[C@@]3(C1)CC[C@@H]1[C@@](C)(CCC[C@]1([C@@H]3CC2)C)C(=O)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O UEDUENGHJMELGK-HYDKPPNVSA-N 0.000 description 3
- 238000002835 absorbance Methods 0.000 description 3
- 235000010418 carrageenan Nutrition 0.000 description 3
- 239000000679 carrageenan Substances 0.000 description 3
- 229920001525 carrageenan Polymers 0.000 description 3
- 229940113118 carrageenan Drugs 0.000 description 3
- 238000006243 chemical reaction Methods 0.000 description 3
- 235000015218 chewing gum Nutrition 0.000 description 3
- 229940112822 chewing gum Drugs 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 238000007796 conventional method Methods 0.000 description 3
- 229940088598 enzyme Drugs 0.000 description 3
- 239000000796 flavoring agent Substances 0.000 description 3
- 235000019634 flavors Nutrition 0.000 description 3
- 230000005764 inhibitory process Effects 0.000 description 3
- 239000008101 lactose Substances 0.000 description 3
- 238000000034 method Methods 0.000 description 3
- 239000012046 mixed solvent Substances 0.000 description 3
- 239000002324 mouth wash Substances 0.000 description 3
- 229940051866 mouthwash Drugs 0.000 description 3
- 239000000523 sample Substances 0.000 description 3
- 235000019333 sodium laurylsulphate Nutrition 0.000 description 3
- 239000000600 sorbitol Substances 0.000 description 3
- 235000010356 sorbitol Nutrition 0.000 description 3
- OHHNJQXIOPOJSC-UHFFFAOYSA-N stevioside Natural products CC1(CCCC2(C)C3(C)CCC4(CC3(CCC12C)CC4=C)OC5OC(CO)C(O)C(O)C5OC6OC(CO)C(O)C(O)C6O)C(=O)OC7OC(CO)C(O)C(O)C7O OHHNJQXIOPOJSC-UHFFFAOYSA-N 0.000 description 3
- 229940013618 stevioside Drugs 0.000 description 3
- 235000019202 steviosides Nutrition 0.000 description 3
- 239000000758 substrate Substances 0.000 description 3
- 229940034610 toothpaste Drugs 0.000 description 3
- 239000000606 toothpaste Substances 0.000 description 3
- UHVMMEOXYDMDKI-JKYCWFKZSA-L zinc;1-(5-cyanopyridin-2-yl)-3-[(1s,2s)-2-(6-fluoro-2-hydroxy-3-propanoylphenyl)cyclopropyl]urea;diacetate Chemical compound [Zn+2].CC([O-])=O.CC([O-])=O.CCC(=O)C1=CC=C(F)C([C@H]2[C@H](C2)NC(=O)NC=2N=CC(=CC=2)C#N)=C1O UHVMMEOXYDMDKI-JKYCWFKZSA-L 0.000 description 3
- NOOLISFMXDJSKH-KXUCPTDWSA-N (-)-Menthol Chemical compound CC(C)[C@@H]1CC[C@@H](C)C[C@H]1O NOOLISFMXDJSKH-KXUCPTDWSA-N 0.000 description 2
- 244000215068 Acacia senegal Species 0.000 description 2
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 2
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- 241000894006 Bacteria Species 0.000 description 2
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 2
- 235000019739 Dicalciumphosphate Nutrition 0.000 description 2
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 2
- 229920000084 Gum arabic Polymers 0.000 description 2
- DFPAKSUCGFBDDF-UHFFFAOYSA-N Nicotinamide Chemical compound NC(=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-UHFFFAOYSA-N 0.000 description 2
- PXIPVTKHYLBLMZ-UHFFFAOYSA-N Sodium azide Chemical compound [Na+].[N-]=[N+]=[N-] PXIPVTKHYLBLMZ-UHFFFAOYSA-N 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 2
- 235000010489 acacia gum Nutrition 0.000 description 2
- 239000000205 acacia gum Substances 0.000 description 2
- 239000000654 additive Substances 0.000 description 2
- 230000000996 additive effect Effects 0.000 description 2
- 239000003463 adsorbent Substances 0.000 description 2
- POJWUDADGALRAB-UHFFFAOYSA-N allantoin Chemical compound NC(=O)NC1NC(=O)NC1=O POJWUDADGALRAB-UHFFFAOYSA-N 0.000 description 2
- 239000007864 aqueous solution Substances 0.000 description 2
- 238000003556 assay Methods 0.000 description 2
- CUFNKYGDVFVPHO-UHFFFAOYSA-N azulene Chemical compound C1=CC=CC2=CC=CC2=C1 CUFNKYGDVFVPHO-UHFFFAOYSA-N 0.000 description 2
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 2
- FUWUEFKEXZQKKA-UHFFFAOYSA-N beta-thujaplicin Chemical compound CC(C)C=1C=CC=C(O)C(=O)C=1 FUWUEFKEXZQKKA-UHFFFAOYSA-N 0.000 description 2
- 235000008429 bread Nutrition 0.000 description 2
- 235000014121 butter Nutrition 0.000 description 2
- 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 2
- 229910000019 calcium carbonate Inorganic materials 0.000 description 2
- 239000001506 calcium phosphate Substances 0.000 description 2
- 238000011088 calibration curve Methods 0.000 description 2
- 235000013353 coffee beverage Nutrition 0.000 description 2
- 235000009508 confectionery Nutrition 0.000 description 2
- 239000006071 cream Substances 0.000 description 2
- 235000011950 custard Nutrition 0.000 description 2
- NEFBYIFKOOEVPA-UHFFFAOYSA-K dicalcium phosphate Chemical compound [Ca+2].[Ca+2].[O-]P([O-])([O-])=O NEFBYIFKOOEVPA-UHFFFAOYSA-K 0.000 description 2
- 229940038472 dicalcium phosphate Drugs 0.000 description 2
- 229910000390 dicalcium phosphate Inorganic materials 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 239000011521 glass Substances 0.000 description 2
- 239000008103 glucose Substances 0.000 description 2
- 229940093915 gynecological organic acid Drugs 0.000 description 2
- 239000004310 lactic acid Substances 0.000 description 2
- 235000014655 lactic acid Nutrition 0.000 description 2
- 235000021374 legumes Nutrition 0.000 description 2
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 2
- XELZGAJCZANUQH-UHFFFAOYSA-N methyl 1-acetylthieno[3,2-c]pyrazole-5-carboxylate Chemical compound CC(=O)N1N=CC2=C1C=C(C(=O)OC)S2 XELZGAJCZANUQH-UHFFFAOYSA-N 0.000 description 2
- 150000007524 organic acids Chemical class 0.000 description 2
- 235000005985 organic acids Nutrition 0.000 description 2
- 239000003960 organic solvent Substances 0.000 description 2
- 239000000049 pigment Substances 0.000 description 2
- LWIHDJKSTIGBAC-UHFFFAOYSA-K potassium phosphate Substances [K+].[K+].[K+].[O-]P([O-])([O-])=O LWIHDJKSTIGBAC-UHFFFAOYSA-K 0.000 description 2
- 238000000746 purification Methods 0.000 description 2
- 239000012264 purified product Substances 0.000 description 2
- 239000002994 raw material Substances 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- CVHZOJJKTDOEJC-UHFFFAOYSA-N saccharin Chemical compound C1=CC=C2C(=O)NS(=O)(=O)C2=C1 CVHZOJJKTDOEJC-UHFFFAOYSA-N 0.000 description 2
- PUZPDOWCWNUUKD-UHFFFAOYSA-M sodium fluoride Chemical compound [F-].[Na+] PUZPDOWCWNUUKD-UHFFFAOYSA-M 0.000 description 2
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 2
- FTLYMKDSHNWQKD-UHFFFAOYSA-N (2,4,5-trichlorophenyl)boronic acid Chemical compound OB(O)C1=CC(Cl)=C(Cl)C=C1Cl FTLYMKDSHNWQKD-UHFFFAOYSA-N 0.000 description 1
- LNAZSHAWQACDHT-XIYTZBAFSA-N (2r,3r,4s,5r,6s)-4,5-dimethoxy-2-(methoxymethyl)-3-[(2s,3r,4s,5r,6r)-3,4,5-trimethoxy-6-(methoxymethyl)oxan-2-yl]oxy-6-[(2r,3r,4s,5r,6r)-4,5,6-trimethoxy-2-(methoxymethyl)oxan-3-yl]oxyoxane Chemical compound CO[C@@H]1[C@@H](OC)[C@H](OC)[C@@H](COC)O[C@H]1O[C@H]1[C@H](OC)[C@@H](OC)[C@H](O[C@H]2[C@@H]([C@@H](OC)[C@H](OC)O[C@@H]2COC)OC)O[C@@H]1COC LNAZSHAWQACDHT-XIYTZBAFSA-N 0.000 description 1
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 1
- IXPNQXFRVYWDDI-UHFFFAOYSA-N 1-methyl-2,4-dioxo-1,3-diazinane-5-carboximidamide Chemical compound CN1CC(C(N)=N)C(=O)NC1=O IXPNQXFRVYWDDI-UHFFFAOYSA-N 0.000 description 1
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 description 1
- MIDXCONKKJTLDX-UHFFFAOYSA-N 3,5-dimethylcyclopentane-1,2-dione Chemical compound CC1CC(C)C(=O)C1=O MIDXCONKKJTLDX-UHFFFAOYSA-N 0.000 description 1
- XGRSAFKZAGGXJV-UHFFFAOYSA-N 3-azaniumyl-3-cyclohexylpropanoate Chemical compound OC(=O)CC(N)C1CCCCC1 XGRSAFKZAGGXJV-UHFFFAOYSA-N 0.000 description 1
- 229920001817 Agar Polymers 0.000 description 1
- POJWUDADGALRAB-PVQJCKRUSA-N Allantoin Natural products NC(=O)N[C@@H]1NC(=O)NC1=O POJWUDADGALRAB-PVQJCKRUSA-N 0.000 description 1
- 244000080767 Areca catechu Species 0.000 description 1
- 235000006226 Areca catechu Nutrition 0.000 description 1
- 206010006326 Breath odour Diseases 0.000 description 1
- 229920002134 Carboxymethyl cellulose Polymers 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 1
- 229920002261 Corn starch Polymers 0.000 description 1
- 239000011627 DL-alpha-tocopherol Substances 0.000 description 1
- 235000001815 DL-alpha-tocopherol Nutrition 0.000 description 1
- NOOLISFMXDJSKH-UHFFFAOYSA-N DL-menthol Natural products CC(C)C1CCC(C)CC1O NOOLISFMXDJSKH-UHFFFAOYSA-N 0.000 description 1
- 229920002307 Dextran Polymers 0.000 description 1
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- OEIJRRGCTVHYTH-UHFFFAOYSA-N Favan-3-ol Chemical compound OC1CC2=CC=CC=C2OC1C1=CC=CC=C1 OEIJRRGCTVHYTH-UHFFFAOYSA-N 0.000 description 1
- 229930091371 Fructose Natural products 0.000 description 1
- 239000005715 Fructose Substances 0.000 description 1
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 1
- 108010010803 Gelatin Proteins 0.000 description 1
- 239000004378 Glycyrrhizin Substances 0.000 description 1
- 239000002211 L-ascorbic acid Substances 0.000 description 1
- 235000000069 L-ascorbic acid Nutrition 0.000 description 1
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 description 1
- 244000024873 Mentha crispa Species 0.000 description 1
- 235000014749 Mentha crispa Nutrition 0.000 description 1
- 244000246386 Mentha pulegium Species 0.000 description 1
- 235000016257 Mentha pulegium Nutrition 0.000 description 1
- 235000004357 Mentha x piperita Nutrition 0.000 description 1
- 102000016943 Muramidase Human genes 0.000 description 1
- 108010014251 Muramidase Proteins 0.000 description 1
- 108010062010 N-Acetylmuramoyl-L-alanine Amidase Proteins 0.000 description 1
- 239000002202 Polyethylene glycol Substances 0.000 description 1
- 239000004793 Polystyrene Substances 0.000 description 1
- CWEZAWNPTYBADX-UHFFFAOYSA-N Procyanidin Natural products OC1C(OC2C(O)C(Oc3c2c(O)cc(O)c3C4C(O)C(Oc5cc(O)cc(O)c45)c6ccc(O)c(O)c6)c7ccc(O)c(O)c7)c8c(O)cc(O)cc8OC1c9ccc(O)c(O)c9 CWEZAWNPTYBADX-UHFFFAOYSA-N 0.000 description 1
- 241000245165 Rhododendron ponticum Species 0.000 description 1
- 241000065614 Schinopsis Species 0.000 description 1
- 241000871328 Schinopsis lorentzii Species 0.000 description 1
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 1
- 239000004141 Sodium laurylsulphate Substances 0.000 description 1
- 229920002125 Sokalan® Polymers 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 241000194017 Streptococcus Species 0.000 description 1
- 241000193987 Streptococcus sobrinus Species 0.000 description 1
- KDYFGRWQOYBRFD-UHFFFAOYSA-N Succinic acid Natural products OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 description 1
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 1
- 244000081822 Uncaria gambir Species 0.000 description 1
- 240000008042 Zea mays Species 0.000 description 1
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 1
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- 239000008272 agar Substances 0.000 description 1
- 235000010419 agar Nutrition 0.000 description 1
- 229960000458 allantoin Drugs 0.000 description 1
- TUFYVOCKVJOUIR-UHFFFAOYSA-N alpha-Thujaplicin Natural products CC(C)C=1C=CC=CC(=O)C=1O TUFYVOCKVJOUIR-UHFFFAOYSA-N 0.000 description 1
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 229940121363 anti-inflammatory agent Drugs 0.000 description 1
- 239000002260 anti-inflammatory agent Substances 0.000 description 1
- 229960005070 ascorbic acid Drugs 0.000 description 1
- 238000013096 assay test Methods 0.000 description 1
- 208000022362 bacterial infectious disease Diseases 0.000 description 1
- GUBGYTABKSRVRQ-QUYVBRFLSA-N beta-maltose Chemical compound OC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@@H]1O GUBGYTABKSRVRQ-QUYVBRFLSA-N 0.000 description 1
- 235000013361 beverage Nutrition 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- KDYFGRWQOYBRFD-NUQCWPJISA-N butanedioic acid Chemical compound O[14C](=O)CC[14C](O)=O KDYFGRWQOYBRFD-NUQCWPJISA-N 0.000 description 1
- FAPWYRCQGJNNSJ-UBKPKTQASA-L calcium D-pantothenic acid Chemical compound [Ca+2].OCC(C)(C)[C@@H](O)C(=O)NCCC([O-])=O.OCC(C)(C)[C@@H](O)C(=O)NCCC([O-])=O FAPWYRCQGJNNSJ-UBKPKTQASA-L 0.000 description 1
- 229960002079 calcium pantothenate Drugs 0.000 description 1
- 159000000007 calcium salts Chemical class 0.000 description 1
- 235000013736 caramel Nutrition 0.000 description 1
- 239000004202 carbamide Substances 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 235000014171 carbonated beverage Nutrition 0.000 description 1
- 239000001768 carboxy methyl cellulose Substances 0.000 description 1
- 235000010948 carboxy methyl cellulose Nutrition 0.000 description 1
- 239000008112 carboxymethyl-cellulose Substances 0.000 description 1
- 229940105329 carboxymethylcellulose Drugs 0.000 description 1
- 230000001013 cariogenic effect Effects 0.000 description 1
- 239000005018 casein Substances 0.000 description 1
- BECPQYXYKAMYBN-UHFFFAOYSA-N casein, tech. Chemical compound NCCCCC(C(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(CC(C)C)N=C(O)C(CCC(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(C(C)O)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(COP(O)(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(N)CC1=CC=CC=C1 BECPQYXYKAMYBN-UHFFFAOYSA-N 0.000 description 1
- 235000021240 caseins Nutrition 0.000 description 1
- 235000019219 chocolate Nutrition 0.000 description 1
- 235000015165 citric acid Nutrition 0.000 description 1
- 235000016213 coffee Nutrition 0.000 description 1
- 235000014510 cooky Nutrition 0.000 description 1
- 235000005822 corn Nutrition 0.000 description 1
- 239000008120 corn starch Substances 0.000 description 1
- 238000012258 culturing Methods 0.000 description 1
- GVJHHUAWPYXKBD-UHFFFAOYSA-N d-alpha-tocopherol Natural products OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 1
- 238000005115 demineralization Methods 0.000 description 1
- 230000002328 demineralizing effect Effects 0.000 description 1
- 210000003298 dental enamel Anatomy 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 235000019329 dioctyl sodium sulphosuccinate Nutrition 0.000 description 1
- ZPWVASYFFYYZEW-UHFFFAOYSA-L dipotassium hydrogen phosphate Chemical compound [K+].[K+].OP([O-])([O-])=O ZPWVASYFFYYZEW-UHFFFAOYSA-L 0.000 description 1
- 235000019797 dipotassium phosphate Nutrition 0.000 description 1
- 229910000396 dipotassium phosphate Inorganic materials 0.000 description 1
- YHAIUSTWZPMYGG-UHFFFAOYSA-L disodium;2,2-dioctyl-3-sulfobutanedioate Chemical compound [Na+].[Na+].CCCCCCCCC(C([O-])=O)(C(C([O-])=O)S(O)(=O)=O)CCCCCCCC YHAIUSTWZPMYGG-UHFFFAOYSA-L 0.000 description 1
- GVGUFUZHNYFZLC-UHFFFAOYSA-N dodecyl benzenesulfonate;sodium Chemical compound [Na].CCCCCCCCCCCCOS(=O)(=O)C1=CC=CC=C1 GVGUFUZHNYFZLC-UHFFFAOYSA-N 0.000 description 1
- 239000002552 dosage form Substances 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 239000003937 drug carrier Substances 0.000 description 1
- IDGUHHHQCWSQLU-UHFFFAOYSA-N ethanol;hydrate Chemical compound O.CCO IDGUHHHQCWSQLU-UHFFFAOYSA-N 0.000 description 1
- 229940044949 eucalyptus oil Drugs 0.000 description 1
- 239000010642 eucalyptus oil Substances 0.000 description 1
- 239000000706 filtrate Substances 0.000 description 1
- 229930182497 flavan-3-ol Natural products 0.000 description 1
- 150000002222 fluorine compounds Chemical class 0.000 description 1
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 1
- 239000008273 gelatin Substances 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 235000011852 gelatine desserts Nutrition 0.000 description 1
- 229960001031 glucose Drugs 0.000 description 1
- 235000001727 glucose Nutrition 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- LPLVUJXQOOQHMX-UHFFFAOYSA-N glycyrrhetinic acid glycoside Natural products C1CC(C2C(C3(CCC4(C)CCC(C)(CC4C3=CC2=O)C(O)=O)C)(C)CC2)(C)C2C(C)(C)C1OC1OC(C(O)=O)C(O)C(O)C1OC1OC(C(O)=O)C(O)C(O)C1O LPLVUJXQOOQHMX-UHFFFAOYSA-N 0.000 description 1
- UYRUBYNTXSDKQT-UHFFFAOYSA-N glycyrrhizic acid Natural products CC1(C)C(CCC2(C)C1CCC3(C)C2C(=O)C=C4C5CC(C)(CCC5(C)CCC34C)C(=O)O)OC6OC(C(O)C(O)C6OC7OC(O)C(O)C(O)C7C(=O)O)C(=O)O UYRUBYNTXSDKQT-UHFFFAOYSA-N 0.000 description 1
- 229960004949 glycyrrhizic acid Drugs 0.000 description 1
- 235000019410 glycyrrhizin Nutrition 0.000 description 1
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 description 1
- 235000001050 hortel pimenta Nutrition 0.000 description 1
- 235000015243 ice cream Nutrition 0.000 description 1
- 239000002440 industrial waste Substances 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 239000003112 inhibitor Substances 0.000 description 1
- 235000015094 jam Nutrition 0.000 description 1
- 235000015110 jellies Nutrition 0.000 description 1
- 239000008274 jelly Substances 0.000 description 1
- 229960001375 lactose Drugs 0.000 description 1
- 239000004325 lysozyme Substances 0.000 description 1
- 235000010335 lysozyme Nutrition 0.000 description 1
- 229960000274 lysozyme Drugs 0.000 description 1
- ZLNQQNXFFQJAID-UHFFFAOYSA-L magnesium carbonate Chemical compound [Mg+2].[O-]C([O-])=O ZLNQQNXFFQJAID-UHFFFAOYSA-L 0.000 description 1
- 239000001095 magnesium carbonate Substances 0.000 description 1
- 229910000021 magnesium carbonate Inorganic materials 0.000 description 1
- 235000019359 magnesium stearate Nutrition 0.000 description 1
- 229940057948 magnesium stearate Drugs 0.000 description 1
- 239000001630 malic acid Substances 0.000 description 1
- 235000011090 malic acid Nutrition 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 238000000691 measurement method Methods 0.000 description 1
- 239000002609 medium Substances 0.000 description 1
- 229940041616 menthol Drugs 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- GBDRMPRTNVKBAD-BYPYZUCNSA-N methyl (2s)-2,5-diamino-5-oxopentanoate Chemical compound COC(=O)[C@@H](N)CCC(N)=O GBDRMPRTNVKBAD-BYPYZUCNSA-N 0.000 description 1
- 229920000609 methyl cellulose Polymers 0.000 description 1
- 239000001923 methylcellulose Substances 0.000 description 1
- 229960002900 methylcellulose Drugs 0.000 description 1
- 235000010981 methylcellulose Nutrition 0.000 description 1
- 235000019796 monopotassium phosphate Nutrition 0.000 description 1
- 229910000402 monopotassium phosphate Inorganic materials 0.000 description 1
- 239000005445 natural material Substances 0.000 description 1
- 229930014626 natural product Natural products 0.000 description 1
- 235000005152 nicotinamide Nutrition 0.000 description 1
- 239000011570 nicotinamide Substances 0.000 description 1
- 239000006072 paste Substances 0.000 description 1
- 239000001814 pectin Substances 0.000 description 1
- 235000010987 pectin Nutrition 0.000 description 1
- 229920001277 pectin Polymers 0.000 description 1
- 239000002304 perfume Substances 0.000 description 1
- 208000028169 periodontal disease Diseases 0.000 description 1
- 238000009160 phytotherapy Methods 0.000 description 1
- 229920001223 polyethylene glycol Polymers 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 229920002223 polystyrene Polymers 0.000 description 1
- GNSKLFRGEWLPPA-UHFFFAOYSA-M potassium dihydrogen phosphate Chemical compound [K+].OP(O)([O-])=O GNSKLFRGEWLPPA-UHFFFAOYSA-M 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 238000004321 preservation Methods 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 229920002414 procyanidin Polymers 0.000 description 1
- OVARTBFNCCXQKS-UHFFFAOYSA-N propan-2-one;hydrate Chemical compound O.CC(C)=O OVARTBFNCCXQKS-UHFFFAOYSA-N 0.000 description 1
- 235000013772 propylene glycol Nutrition 0.000 description 1
- 235000011962 puddings Nutrition 0.000 description 1
- 229940085605 saccharin sodium Drugs 0.000 description 1
- 239000012488 sample solution Substances 0.000 description 1
- 235000010413 sodium alginate Nutrition 0.000 description 1
- 239000000661 sodium alginate Substances 0.000 description 1
- 229940005550 sodium alginate Drugs 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 229940080264 sodium dodecylbenzenesulfonate Drugs 0.000 description 1
- 239000004320 sodium erythorbate Substances 0.000 description 1
- 235000010352 sodium erythorbate Nutrition 0.000 description 1
- 239000011775 sodium fluoride Substances 0.000 description 1
- 235000013024 sodium fluoride Nutrition 0.000 description 1
- 229960004711 sodium monofluorophosphate Drugs 0.000 description 1
- 239000012064 sodium phosphate buffer Substances 0.000 description 1
- RBWSWDPRDBEWCR-RKJRWTFHSA-N sodium;(2r)-2-[(2r)-3,4-dihydroxy-5-oxo-2h-furan-2-yl]-2-hydroxyethanolate Chemical compound [Na+].[O-]C[C@@H](O)[C@H]1OC(=O)C(O)=C1O RBWSWDPRDBEWCR-RKJRWTFHSA-N 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 239000006188 syrup Substances 0.000 description 1
- 235000020357 syrup Nutrition 0.000 description 1
- 235000002906 tartaric acid Nutrition 0.000 description 1
- 239000011975 tartaric acid Substances 0.000 description 1
- 229960000984 tocofersolan Drugs 0.000 description 1
- 239000007078 todd-hewitt medium Substances 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- 239000002023 wood Substances 0.000 description 1
- GVJHHUAWPYXKBD-IEOSBIPESA-N α-tocopherol Chemical compound OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-IEOSBIPESA-N 0.000 description 1
- 229930007845 β-thujaplicin Natural products 0.000 description 1
Landscapes
- Confectionery (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Cosmetics (AREA)
- Medicines Containing Plant Substances (AREA)
- Compounds Of Unknown Constitution (AREA)
Abstract
Description
【0001】[0001]
【産業上の利用分野】本発明は樹木の心材や樹皮に由来
する縮合型タンニンを有効成分とするグルコシルトラン
スフェラーゼ阻害剤に関し、更に詳細には、口腔衛生剤
等の抗う蝕剤や抗う蝕性食品の有効成分として利用でき
る、上記タンニンを含有するグルコシルトランスフェラ
ーゼ阻害剤並びに該タンニンの製造方法に関する。BACKGROUND OF THE INVENTION 1. Field of the Invention The present invention relates to a glucosyltransferase inhibitor containing condensed tannin derived from heartwood and bark of trees as an active ingredient. More specifically, it is an anticaries agent such as an oral hygiene agent or an anti-caries food. The present invention relates to a glucosyltransferase inhibitor containing the above-mentioned tannin, which can be used as an active ingredient, and a method for producing the tannin.
【0002】[0002]
【従来の技術】う蝕の原因については過去、種々の仮説
が提唱されたが、現在ではミラー(Miller)の化学細菌
説に基づく細菌感染症の一種であると認められている。
この説に基づいたう蝕の発生機構は以下のごとくであ
る。 即ち、口腔連鎖球菌、特にストレプトコッカス・
ミュータンス(Streptococcus mutans)が産生するグル
コシルトランスフェラーゼという酵素が、まず、口中の
しょ糖を基質として、粘着性、不溶性の多糖(グルカ
ン)を生成する。 ストレプトコッカス・ミュータンス
(以下、「S.ミュータンス」と略称する)の菌体は、
生成したグルカンによって、歯表面に付着して菌塊(歯
垢)を形成する。2. Description of the Related Art Although various hypotheses have been proposed in the past regarding the cause of dental caries, it is now recognized as a kind of bacterial infectious disease based on Miller's theory of chemical bacteria.
The caries generation mechanism based on this theory is as follows. That is, oral streptococci, especially Streptococcus
First, an enzyme called glucosyltransferase produced by mutans (Streptococcus mutans) produces a sticky, insoluble polysaccharide (glucan) using sucrose in the mouth as a substrate. Streptococcus mutans (hereinafter referred to as "S. mutans") cells are
The generated glucan attaches to the tooth surface and forms a bacterial mass (plaque).
【0003】この歯垢中ではS.ミュータンスを始め種
々の微生物が共生、繁殖しているが、これら微生物の代
謝によって有機酸が産生され、この有機酸の作用で歯表
面のpHが低下し、エナメル質表面に脱灰が生じて、う
蝕が発生、進行する。また、歯垢形成はう蝕のほかに、
歯周病や口臭の原因となるとされている。In this dental plaque, various microorganisms including S. mutans coexist and propagate. The metabolism of these microorganisms produces organic acids, and the action of these organic acids lowers the pH of the tooth surface. , Demineralization occurs on the enamel surface, causing caries to develop. In addition to dental caries, plaque formation
It is said to cause periodontal disease and bad breath.
【0004】このようにS.ミュータンスを中心とする
口腔連鎖球菌によって形成される歯垢がう蝕の原因とな
っていることから、歯垢形成を抑えることが、ひいては
う蝕の発生を予防する有効な手段となりうる。As described above, plaque formed by S. mutans and other oral streptococci causes dental caries. Therefore, suppressing the formation of dental plaque prevents the occurrence of dental caries. Can be an effective means of
【0005】従来から、う蝕を予防するために、口腔内
微生物の増殖を抑制するための抗菌剤、口腔内微生物の
産生するグルコシルトランスフェラーゼの作用を抑える
阻害剤、しょ糖を基質とし、グルコシルトランスフェラ
ーゼにより形成されたグルカンを分解する酵素等の抗う
蝕物質等が種々研究され、更に歯垢形成の基質とならな
い非う蝕性の糖類についても種々の研究がなされてい
る。Conventionally, in order to prevent dental caries, an antibacterial agent for suppressing the growth of oral microorganisms, an inhibitor for suppressing the action of glucosyltransferase produced by oral microorganisms, sucrose as a substrate, and glucosyltransferase Various studies have been conducted on anti-carious substances such as enzymes that decompose the formed glucan, and various studies have also been conducted on non-cariogenic saccharides that do not serve as a substrate for plaque formation.
【0006】近年、抗う蝕物質として植物成分、特にタ
ンニン類が注目されるに至っている。 例えば、特開昭
59−152311号公報にはフラバン−3−オールの
縮合物である縮合型タンニンを配合する口腔用組成物が
開示されている。In recent years, plant components, especially tannins, have been attracting attention as anticaries substances. For example, JP-A-59-152311 discloses an oral composition containing a condensed tannin which is a condensate of flavan-3-ol.
【0007】この公報では、大黄タンニン、何首鳥タン
ニンおよび雅黄タンニンについて、実際にグルコシルト
ランスフェラーゼ阻害活性が試験されているが、これは
不十分なものであり、到底実用に耐えられるものではな
かった。また、ビンロウジュの実より単離した2〜4量
体のプロシアニジン類のグルコシルトランスフェラーゼ
阻害活性〔Sumitra Hada et al. ; Phytotherapy Resea
rch 3(4),140-144(1989)〕についても試験されている
が、これも同様に十分といえないものである。[0007] In this publication, the glucosyltransferase inhibitory activity is actually tested for rhododendron tannin, swordbird tannin and yam tannin, but this is insufficient and cannot be put to practical use at all. It was In addition, the glucosyltransferase inhibitory activity of the 2- to 4-meric procyanidins isolated from areca nut [Sumitra Hada et al .; Phytotherapy Resea
rch 3 (4), 140-144 (1989)] have also been tested, but this too is less than adequate.
【0008】[0008]
【発明が解決しようとする課題】従って、十分強力な効
果を有し、かつ人体に対して安全性等の面でなんら問題
を起こすことのない抗う蝕剤の開発が課題として残され
ていた。Therefore, the development of an anticaries agent which has a sufficiently strong effect and does not cause any problems with respect to the human body in terms of safety has been left as a problem.
【0009】[0009]
【課題を解決するための手段】本発明者らは、このよう
な事情に鑑み、歯垢の形成あるいはう蝕の発生を効果的
に抑制し、かつ、人体に対して無害である物質を天然中
から見いだすべく鋭意研究を行った結果、樹木中に存在
する特定の縮合型タンニンは効果的にグルコシルトラン
スフェラーゼを抑制し、かつ安全なものであることを見
いだし、本発明を完成させるに至った。In view of such circumstances, the present inventors have found that a substance that effectively suppresses the formation of dental plaque or the occurrence of dental caries and that is harmless to the human body is used as a natural substance. As a result of earnest research to find out from the inside, it was found that the specific condensed tannin present in the tree effectively suppressed glucosyltransferase and was safe, and completed the present invention.
【0010】すなわち、本発明の目的は、樹木の心材ま
たは樹皮に由来する縮合型タンニンを有効成分とするグ
ルコシルトランスフェラーゼ阻害剤を提供することであ
る。また、本発明の他の目的は、上記グルコシルトラン
スフェラーゼ阻害剤を有効成分とする、口腔衛生剤等の
抗う蝕剤および抗う蝕性食品を提供することである。更
に、本発明の別の目的は、樹木の心材または樹皮を溶媒
抽出後、該抽出物を吸着カラムクロマトグラフィーに付
すことを特徴とするグルコシルトランスフェラーゼ阻害
作用を有する抗う蝕性物質の製造方法を提供することで
ある。That is, an object of the present invention is to provide a glucosyltransferase inhibitor containing a condensed tannin derived from the heartwood or bark of trees as an active ingredient. Another object of the present invention is to provide an anticaries agent such as an oral hygiene agent and an anticaries food containing the above-mentioned glucosyltransferase inhibitor as an active ingredient. Still another object of the present invention is to provide a method for producing an anticaries agent having a glucosyltransferase inhibitory activity, which comprises subjecting a heartwood or a bark of a tree to solvent extraction and subjecting the extract to adsorption column chromatography. It is to be.
【0011】本発明における樹木の心材または樹皮に由
来する縮合型タンニン(以下、「樹木由来タンニン」と
いう)としては、種々の樹木の心材または樹皮を溶媒で
抽出した抽出物そのものを用いてもよいし、更にこの抽
出物から精製したものを用いてもよい。As the condensed tannin derived from the heartwood or bark of the tree in the present invention (hereinafter referred to as "tree-derived tannin"), the extract itself obtained by extracting the heartwood or bark of various trees with a solvent may be used. Alternatively, a product purified from this extract may be used.
【0012】抽出原料として用いられる樹木としては、
特に限定されるものではないが、好ましくはウルシ科
(Anacardaceae)、マツ科(Pinaceae)、マメ科(Legu
minosae)の樹木の心材または樹皮が用いられ、より好
適にはアカシヤ樹皮、カラマツ樹皮等が利用される。The tree used as the extraction raw material is
It is not particularly limited, but is preferably a family of Alacaceae (Anacardaceae), a family of Pinaceae, and a family of legumes (Legu).
minosae) heartwood or bark, and more preferably Akashiya bark, larch bark, and the like.
【0013】また、樹木の心材や樹皮を抽出するための
溶媒についても特に限定するものではないが、メタノー
ル、エタノール、アセトン、酢酸エチル、水、熱水、あ
るいはこれらの混合溶媒系を用いることが出来る。 こ
の時の抽出温度も特に限定するものではないが、5℃〜
溶媒の沸点以下、特に15〜35℃が好ましい。 また
抽出時間も、特に限定するものではないが、2日以内が
好適である。 なお、抽出は遮光下で行うことがより好
適である。Further, the solvent for extracting the heartwood and bark of the tree is not particularly limited, but methanol, ethanol, acetone, ethyl acetate, water, hot water, or a mixed solvent system thereof is used. I can. The extraction temperature at this time is also not particularly limited, but is 5 ° C to
It is preferably not higher than the boiling point of the solvent, particularly preferably 15 to 35 ° C. The extraction time is also not particularly limited, but it is preferably within 2 days. In addition, it is more preferable to perform the extraction under light shielding.
【0014】なお、上記のように樹木の心材や樹皮を抽
出することに代えて、抽出物として市販のケブラコタン
ニン、ワットルタンニン、ガンビールタンニン、カッチ
タンニン等を用いてもよい。 このうちケブラコタンニ
ンとは、ウルシ科植物 Schinopsis lorentzii Engl. や
Schinopsis balanse Engl. などの心材の縮合型タンニ
ンであり、ワットルタンニンとは、マメ科 Acacia moli
ssima の樹皮の縮合型タンニンである。In place of extracting the heartwood and bark of the tree as described above, commercially available kebracotannin, wattle tannin, gambir tannin, and catatinnin may be used as the extract. Of these, kebraco tannin is the sumacaceae plant Schinopsis lorentzii Engl.
It is a condensed tannin of heartwood such as Schinopsis balanse Engl. And Wattle tannin is a legume, Acacia moli.
It is a condensed tannin of the bark of ssima.
【0015】上記のようにして得られた抽出物や市販の
ケブラコタンニン、ワットルタンニン等でも一応のグル
コシルトランスフェラーゼ阻害作用は認められるが、実
際の使用に当っては、これらの精製物を用いることがよ
り好ましい。Although the extract obtained as described above and commercially available kebracotannin, wattle tannin and the like have a tentative glucosyltransferase inhibitory action, these purified products are used in actual use. Is more preferable.
【0016】精製物を得るための精製手段としては、セ
ファデックス LH−20(米国、ファルマシア社
製)、ダイヤイオン HP−20(三菱化成工業製)、
セパビーズ HP1MG(三菱化成工業製)、トヨパー
ル HW40F(東洋曹達工業製)等の合成吸着剤カラ
ムなどを用いるカラムクロマトグラフィーなどが挙げら
れる。As a purification means for obtaining a purified product, Sephadex LH-20 (manufactured by Pharmacia, USA), Diaion HP-20 (manufactured by Mitsubishi Kasei Kogyo),
Column chromatography using synthetic adsorbent columns such as SepaBeads HP1MG (manufactured by Mitsubishi Kasei Co., Ltd.) and Toyopearl HW40F (manufactured by Toyo Soda Co., Ltd.) can be used.
【0017】具体的には、抽出物や市販のケブラコタン
ニン、ワットルタンニン等を少量の水、メタノール、エ
タノール等の溶媒あるいはこれらの混合溶媒に溶解し、
上記合成吸着剤カラムに吸着させた後、水で充分に洗浄
し、メタノール、エタノール等の親水性有機溶媒あるい
はこれらの混合溶媒で溶出させれば良い。Specifically, the extract, commercially available kebracotannin, wattle tannin and the like are dissolved in a small amount of water, a solvent such as methanol or ethanol, or a mixed solvent thereof,
After being adsorbed on the synthetic adsorbent column, it may be sufficiently washed with water and eluted with a hydrophilic organic solvent such as methanol or ethanol or a mixed solvent thereof.
【0018】精製工程により得られる溶出画分ごとに平
均分子量〔数平均分子量(Mn)、重量平均分子量(M
w)〕を算出することが出来る。The average molecular weight [number average molecular weight (Mn), weight average molecular weight (M
w)] can be calculated.
【0019】得られた樹木由来タンニンは、その重量平
均分子量が800〜10,000程度のものであり、分
子量から判断される重合度は3〜30のものである。
このうち、特にグルコシルトランスフェラーゼ阻害作用
の強いものとしては、重量平均分子量が1,500〜6,
000で、重合度が5〜20のものが挙げられる。更
に、格別にグルコシルトランスフェラーゼ阻害作用の強
いものとしては、重量平均分子量が1,500〜4,50
0で、重合度が5〜15のものが挙げられる。なお、分
子量値の範囲と重量平均分子量との関係は、樹木由来タ
ンニンの場合、最小分子量値が重量平均分子量値の約1
/4、最大分子量値が重量平均分子量値の約2倍であ
る。The obtained tree-derived tannin has a weight average molecular weight of about 800 to 10,000 and a degree of polymerization of 3 to 30 as judged from the molecular weight.
Among them, those having a particularly strong glucosyltransferase inhibitory action have a weight average molecular weight of 1,500 to 6,
And the degree of polymerization is 5 to 20. Furthermore, as a substance having a particularly strong glucosyltransferase inhibitory action, a weight average molecular weight of 1,500 to 4,50
It is 0 and the degree of polymerization is 5 to 15. In the case of tree-derived tannin, the minimum molecular weight value is about 1 of the weight average molecular weight value.
/ 4, the maximum molecular weight value is about twice the weight average molecular weight value.
【0020】本発明の樹木由来タンニンとして、抽出物
を用いる場合でも、またより精製して純度を上げた精製
物を用いる場合でも、得られたそのままのもの、濃縮し
たもの、溶媒を除去した乾燥物などいかなる状態のもの
でも使用することが出来るが、保存性、有機溶媒の安全
性の点で乾燥物の状態にするのが好ましい。Whether an extract is used as the tree-derived tannin of the present invention or a refined product obtained by further purifying the tannin is used, the obtained raw product, a concentrated product, a solvent-free dried product are used. Although it can be used in any state such as a product, it is preferable to make it in a dried state from the viewpoint of storability and safety of organic solvent.
【0021】本発明のグルコシルトランスフェラーゼ阻
害剤は、上記のようにして得られた樹木由来タンニンを
有効成分とし、これを公知の薬学的に許容される担体と
組み合わせることにより製造される。The glucosyltransferase inhibitor of the present invention is produced by using the tree-derived tannin obtained as described above as an active ingredient and combining this with a known pharmaceutically acceptable carrier.
【0022】本発明のグルコシルトランスフェラーゼ阻
害剤は、主に抗う蝕の目的のための抗う蝕剤、例えば口
腔衛生剤や抗う蝕性食品用添加剤などに用いることが出
来る。 口腔衛生剤としては、歯磨、洗口液、トローチ
等の剤形のものが挙げられ、その製造に当っては、例え
ば、炭酸カルシウム、第二リン酸カルシウム、無水ケイ
酸、炭酸マグネシウム、グリセリン、ソルビトール、プ
ロピレングリコール、ポリエチレングリコール、カルボ
キシメチルセルロース、メチルセルロース、アルギン酸
ソーダ、カラギーナン、カルボキシビニルポリマー、ジ
オクチルスルホコハク酸ソーダ、ラウリル硫酸ナトリウ
ム、ドデシルベンゼンスルホン酸ナトリウム、パラオキ
シ安息香酸ブチル、ヒノキチオール、アラントイン、グ
リチルリチン、アルコール、アラビアゴム、デンプン、
コーンスターチ、サッカリンナトリウム、ステビオサイ
ド、ブドウ糖、乳糖、ステアリン酸マグネシウム、リン
酸一カリウム、リン酸二カリウム、メントール、ユーカ
リ油、ペッパーミント、スペアミント、色素等の他、フ
ッ化ナトリウム、モノフルオロリン酸ナトリウム等のフ
ッ化物、塩化リゾチーム、アズレン等の抗炎症剤、塩化
ナトリウム等の通常使用される成分を適宣配合すること
ができる。The glucosyltransferase inhibitor of the present invention can be used mainly as an anticaries agent for the purpose of anticaries, for example, an oral hygiene agent and an additive for anticaries foods. Examples of the oral hygiene agent include toothpaste, mouthwash, troches and the like, and in the production thereof, for example, calcium carbonate, dicalcium phosphate, silicic anhydride, magnesium carbonate, glycerin, sorbitol, Propylene glycol, polyethylene glycol, carboxymethylcellulose, methylcellulose, sodium alginate, carrageenan, carboxyvinyl polymer, sodium dioctylsulfosuccinate, sodium lauryl sulfate, sodium dodecylbenzenesulfonate, butyl paraoxybenzoate, hinokitiol, allantoin, glycyrrhizin, alcohol, gum arabic , Starch,
Corn starch, sodium saccharin, stevioside, glucose, lactose, magnesium stearate, monopotassium phosphate, dipotassium phosphate, menthol, eucalyptus oil, peppermint, spearmint, pigments, sodium fluoride, sodium monofluorophosphate, etc. Fluorides, anti-inflammatory agents such as lysozyme chloride and azulene, and commonly used components such as sodium chloride can be appropriately blended.
【0023】また、本発明の抗う蝕剤は、抗う蝕を目的
として各種食品中に添加する剤形のものとすることがで
きる。食品の例としては、練りあん、カステラ、水よう
かん、どら焼きの皮、スポンジケーキ、バターケーキ、
ババロア、カスタードクリーム、バタークリーム、カス
タードプディング、クッキー、菓子パン、蒸しパン、ジ
ャム、乳酸菌飲料、炭酸飲料、コーヒー飲料、コーヒー
ゼリー、キャラメル、アイスクリーム、チューインガ
ム、ジュース、キャンディー、チョコレート等が挙げら
れ、その製造にはその種類に応じて通常使用される適宜
な成分を使用することが出来る。The anti-caries agent of the present invention may be in a dosage form to be added to various foods for the purpose of anti-caries. Examples of foods include paste, castella, water yokan, dorayaki peel, sponge cake, butter cake,
Bavaroa, custard cream, butter cream, custard pudding, cookies, sweet bread, steamed bread, jam, lactic acid bacteria beverage, carbonated beverage, coffee beverage, coffee jelly, caramel, ice cream, chewing gum, juice, candy, chocolate, and the like. In the production, appropriate components usually used can be used depending on the kind.
【0024】食品において使用される成分の例として
は、ブドウ糖、果糖、ショ糖、マルトース、ソルビトー
ル、ステビオサイド、コーンシロップ、乳糖、クエン
酸、酒石酸、リンゴ酸、コハク酸、乳酸、L−アスコル
ビン酸、dl−α−トコフェロール、エリソルビン酸ナ
トリウム、グリセリン、プロピレングリコール、グリセ
リン脂肪酸エステル、ポリグリセリン脂肪酸エステル、
ショ糖脂肪酸エステル、ソルビタン脂肪酸エステル、プ
ロピレングリコール脂肪酸エステル、アラビアガム、カ
ラギーナン、カゼイン、ゼラチン、ペクチン、寒天、ビ
タミンB類、ニコチン酸アミド、パントテン酸カルシウ
ム、アミノ酸類、カルシウム塩類、色素、香料、保存剤
等、通常の食品原料として使用されているものを挙げる
ことができる。Examples of components used in foods include glucose, fructose, sucrose, maltose, sorbitol, stevioside, corn syrup, lactose, citric acid, tartaric acid, malic acid, succinic acid, lactic acid, L-ascorbic acid, dl-α-tocopherol, sodium erythorbate, glycerin, propylene glycol, glycerin fatty acid ester, polyglycerin fatty acid ester,
Sucrose fatty acid ester, sorbitan fatty acid ester, propylene glycol fatty acid ester, gum arabic, carrageenan, casein, gelatin, pectin, agar, vitamin Bs, nicotinic acid amide, calcium pantothenate, amino acids, calcium salts, pigments, flavors, preservation Examples include agents that are used as usual food materials, such as agents.
【0025】なお、本発明の抗う蝕剤は、これを砂糖と
組合せて抗う蝕性砂糖とすることができるが、食品に砂
糖と抗う蝕剤を添加する場合には、これに替えてこの抗
う蝕性砂糖を利用することも可能である。The anti-caries agent of the present invention can be combined with sugar to form an anti-caries sugar, but when sugar and an anti-caries agent are added to food, the anti-caries agent is replaced with the anti-caries agent. It is also possible to use edible sugar.
【0026】本発明のタンニンは、樹木の心材または樹
皮に由来する天然物であるので、安全性の点では問題な
いが、本発明のタンニンを口腔用剤、食品などに配合す
るに際して、味、色、香りなどの点で0.0001〜0.
5%の濃度範囲とすることが好ましく、特に0.001
〜0.2%の濃度範囲とすることが好ましい。The tannin of the present invention is a natural product derived from the heartwood or bark of trees, so there is no problem in terms of safety. However, when the tannin of the present invention is added to oral preparations, foods, etc., the taste, In terms of color and scent, 0.0001-0.
A concentration range of 5% is preferred, especially 0.001
It is preferable to set the concentration range to 0.2%.
【0027】[0027]
【発明の効果】本発明で用いる樹木由来タンニンは、極
めて強力なグルコシルトランスフェラーゼ阻害作用を有
し、歯垢形成を顕著に抑制するとともに、それ自身には
特異な味、におい等がないため、任意の量で薬剤や食品
等に配合することが出来るものである。従って、この樹
木由来のタンニンを有効成分とする本発明のグルコシル
トランスフェラーゼ阻害剤は、う蝕の予防等に利用され
る抗う蝕剤や抗う蝕性食品の添加成分として有利に利用
することができるものである。INDUSTRIAL APPLICABILITY The tree-derived tannin used in the present invention has an extremely strong glucosyltransferase inhibitory effect, remarkably suppresses the formation of plaque, and does not have a peculiar taste or odor. It can be added to drugs, foods, etc. in the amount of. Therefore, the glucosyltransferase inhibitor of the present invention containing the tannin derived from the tree as an active ingredient can be advantageously used as an additive ingredient of an anti-caries agent or an anti-caries food used for the prevention of caries and the like. Is.
【0028】また、現在、日本では年間1億2000万
立方メートルの木材が消費されており、そのうちの10
〜20%の樹皮は産業廃棄物となっているが、本発明の
樹木由来タンニンは、その樹皮から得ることができるの
で資源の有効利用としての効果もある。At present, 120 million cubic meters of wood are consumed annually in Japan, 10 of which are consumed.
Although ~ 20% of the bark is industrial waste, the tree-derived tannin of the present invention can be obtained from the bark, and thus has an effect of effective use of resources.
【0029】[0029]
【実施例】次に本発明の樹木由来タンニンの製造法、高
活性物質の精製法、分子量測定法、グルコシルトランス
フェラーゼ阻害活性の検定試験に関する実施例を挙げて
本発明を更に詳細に説明するが、本発明はこれら実施例
などになんら制約されるものではない。[Examples] Next, the present invention will be described in more detail with reference to Examples relating to a method for producing a tree-derived tannin of the present invention, a method for purifying a highly active substance, a molecular weight measurement method, and an assay test for glucosyltransferase inhibitory activity. The present invention is not limited to these examples.
【0030】実 施 例 1 樹木由来タンニンの製造:原料としてアカシア樹皮
(A)およびカラマツ樹皮(K)を用い、樹木由来タン
ニンを製造した。 すなわち、まず各樹皮1kgを60
メッシュ程度に粉砕し、これをアセトン−水(7:3v
/v)10リットルで抽出した。 抽出は25℃、2日
間行い、これをグラスフィルターで濾過した。 得られ
た濾液を減圧下濃縮し、粉末残査をそれぞれ107gお
よび210g得た。Example 1 Production of tree-derived tannins: Tree-derived tannins were produced using acacia bark (A) and larch bark (K) as raw materials. That is, first 60 kg of each bark
It is crushed to about mesh, and this is acetone-water (7: 3v
/ V) extracted with 10 liters. The extraction was performed at 25 ° C. for 2 days, and this was filtered with a glass filter. The obtained filtrate was concentrated under reduced pressure to obtain powder residues of 107 g and 210 g, respectively.
【0031】実 施 例 2 樹木由来タンニンの精製:実施例1で得られたアカシア
樹皮およびカラマツ樹皮からの抽出物、市販のワットル
タンニンおよびケブラコタンニンを、次のようにして精
製した。すなわち、各抽出物またはタンニンの5gを水
−エタノール(1:1v/v)10mlに溶解し、セフ
ァデックスLH−20(米国、ファルマシア社製)のカ
ラム(φ3cm×100cm)に吸着させた。 2リッ
トルの水で洗浄後、順にエタノール、メタノール、アセ
トンそれぞれ2リットルずつで溶出し、得られた画分を
減圧下濃縮し、それぞれエタノール溶出画分(EE)、
メタノール溶出画分(ME)、アセトン溶出画分(A
E)とした。Example 2 Purification of tree-derived tannins: The extracts from the acacia bark and larch bark obtained in Example 1, the commercially available wattle tannins and quebraco tannins were purified as follows. That is, 5 g of each extract or tannin was dissolved in 10 ml of water-ethanol (1: 1 v / v) and adsorbed on a column (φ3 cm × 100 cm) of Sephadex LH-20 (manufactured by Pharmacia, USA). After washing with 2 liters of water, eluting with 2 liters each of ethanol, methanol, and acetone in order, the obtained fractions were concentrated under reduced pressure, and the ethanol elution fractions (EE),
Methanol elution fraction (ME), acetone elution fraction (A
E).
【0032】その結果、アカシア樹皮からは、アカシア
樹皮抽出物のエタノール溶出画分(A−EE)0.75
g、同メタノール溶出画分(A−ME)3.25g、同
アセトン溶出画分(A−AE)0.70gが、カラマツ
樹皮からは、カラマツ樹皮抽出物のエタノール溶出画分
(K−EE)0.9g、同メタノール溶出画分(K−M
E)1.50g、同アセトン溶出画分(K−AE)2.2
5gがそれぞれ得られた。As a result, from the acacia bark, the ethanol elution fraction (A-EE) of the acacia bark extract was 0.75.
g, the same methanol elution fraction (A-ME) 3.25 g, and the same acetone elution fraction (A-AE) 0.70 g from the larch bark, the ethanol elution fraction (K-EE) of the larch bark extract. 0.9 g, the same methanol elution fraction (KM
E) 1.50 g, same acetone elution fraction (K-AE) 2.2
5 g each was obtained.
【0033】また、ワットルタンニンからは、そのエタ
ノール溶出画分(W−EE)0.25g、同メタノール
溶出画分(W−ME)2.90g、同アセトン溶出画分
(W−AE)0.50gが、ケブラコタンニンからは、
そのエタノール溶出画分(Q−EE)0.60g、同メ
タノール溶出画分(Q−ME)1.75g、同アセトン
溶出画分(Q−AE)0.90gがそれぞれ得られた。From Wattle tannin, the ethanol elution fraction (W-EE) 0.25 g, the methanol elution fraction (W-ME) 2.90 g, and the acetone elution fraction (W-AE) 0 were obtained. .50 g from Kebraco Tannin
The ethanol elution fraction (Q-EE) was 0.60 g, the methanol elution fraction (Q-ME) was 1.75 g, and the acetone elution fraction (Q-AE) was 0.90 g.
【0034】実 施 例 3 各画分の平均分子量測定:ショーデックス(Shode
x)カラムを用いて、実施例2で得られた各画分の数平
均分子量と重量平均分子量を測定した。すなわち、各試
料のサンプル2mgをテトラヒドロフラン10mlに溶
解し、これをショーデックス(Shodex)KF−8
02および804(昭和電工)カラムに吸着させた後、
テトラヒドロフランで溶出し、各画分成分の溶出を28
0nmで検出することにより、各画分の数平均分子量と
重量平均分子量を測定した。 検量線はポリスチレン標
準品を用いて作成した。Example 3 Measurement of average molecular weight of each fraction: Shodex
x) The column was used to measure the number average molecular weight and the weight average molecular weight of each fraction obtained in Example 2. That is, 2 mg of each sample was dissolved in 10 ml of tetrahydrofuran, and this was dissolved in Shodex KF-8.
02 and 804 (Showa Denko) columns after adsorption,
Elute with tetrahydrofuran to elute each fraction component with 28
The number average molecular weight and the weight average molecular weight of each fraction were measured by detecting at 0 nm. The calibration curve was created using polystyrene standards.
【0035】各画分の重合度は最大ピークを示す最大含
有分子種について算出した。すなわち、検量線からその
分子量を算出後、1ユニット290と考えて重合度を算
出した。この結果を第1表にまとめた。The degree of polymerization of each fraction was calculated for the maximum contained molecular species showing the maximum peak. That is, after calculating the molecular weight from the calibration curve, the degree of polymerization was calculated considering 1 unit 290. The results are summarized in Table 1.
【0036】 [0036]
【0037】実 施 例 4 グルコシルトランスフェラーゼ阻害活性の検定:下記方
法に従い、本発明タンニンのグルコシルトランスフェラ
ーゼ阻害活性を調べた。すなわち、ショ糖 5.0%、デ
キストランT−10 0.5%及びアジ化ナトリウム 0.
5%を含む500mMリン酸ナトリウム緩衝液(pH
6.0) 0.6mlおよび被験試料水溶液 0.15ml
に、トッド−ヒューウィット(Todd-Hewitt)培地で培
養したストレプトコッカス・ミュータンス(Streptococ
cus mutans)MT8148株菌体から8M尿素で抽出し
たグルコシルトランスフェラーゼ酵素液〔S. Hamada et
al.; J. Gen. Microbiol., 135, 335-344(1989)〕を加
え、更に全量3mlとなる量の水を加えて反応系を作成
した。 この反応系を、ガラス試験管内、37℃で3時
間反応させた。 この際に添加する酵素量は、37℃、
3時間の反応で550nmの吸光度が約1.0になるよ
うに設定した。Example 4 Assay of glucosyltransferase inhibitory activity: The tannin of the present invention was tested for glucosyltransferase inhibitory activity according to the following method. That is, sucrose 5.0%, dextran T-10 0.5% and sodium azide 0.0.
500 mM sodium phosphate buffer containing 5% (pH
6.0) 0.6 ml and test sample aqueous solution 0.15 ml
And Streptococcus mutans cultured in Todd-Hewitt medium.
cus mutans) MT8148 strain glucosyltransferase enzyme solution extracted with 8M urea [S. Hamada et al.
al .; J. Gen. Microbiol., 135, 335-344 (1989)], and a total amount of 3 ml of water was added to prepare a reaction system. This reaction system was reacted in a glass test tube at 37 ° C. for 3 hours. The amount of enzyme added at this time is 37 ° C,
The absorbance at 550 nm was set to about 1.0 after the reaction for 3 hours.
【0038】生成した不溶性グルカンを超音波破砕し、
550nmの吸光度(A)を測定し、試料液の代わりに
水を用いたときの吸光度をコントロール(B)として、
以下の計算式で阻害率(%)を求めた。 阻害率(%) = (B−A)×100/B 実施例3で得た各樹木由来タンニンのグルコシルトラン
スフェラーゼ阻害率を第2表に示す。The produced insoluble glucan is ultrasonically disrupted,
The absorbance (A) at 550 nm was measured, and the absorbance when water was used instead of the sample solution was used as a control (B).
The inhibition rate (%) was calculated by the following formula. Inhibition rate (%) = (BA) x 100 / B Table 2 shows the glucosyltransferase inhibition rate of the tannins derived from each tree obtained in Example 3.
【0039】 [0039]
【0040】実 施 例 5 歯垢形成抑制作用の検定:下記方法に従い、本発明タン
ニンの歯垢形成抑制作用を調べた。すなわち、ショ糖
5%および被験試料水溶液を含むイーグル(Eagle)培
地(ニッスイ製薬)を用い、斜めに傾斜させた試験管
中、37℃ででストレプトコッカス・ソブリヌス(Stre
ptococcus sobrinus)6715株を培養した。2日間培
養後、試験管壁に付着したグルカン−菌体複合体(歯
垢)の重量を測定し、これを歯垢形成量とした。 その
結果を第3表に示す。Example 5 Assay of Plaque Formation Inhibitory Action: The plaque formation inhibitory action of the tannin of the present invention was examined according to the following method. That is, sucrose
Streptococcus sobrinus (Stre) at 37 ° C. in an obliquely inclined test tube using an Eagle medium (Nissui Pharmaceutical Co., Ltd.) containing 5% and a test sample aqueous solution.
Strain 6715 of Ptococcus sobrinus was cultured. After culturing for 2 days, the weight of the glucan-bacterial body complex (plaque) attached to the wall of the test tube was measured, and this was defined as the amount of plaque formation. The results are shown in Table 3.
【0041】 [0041]
【0042】実 施 例 6 歯 磨 き 剤:下記組成により、常法に従って歯磨き
剤を調製した。 ( 組 成 ) 重 量 部 第2リン酸カルシウム 42 グリセリン 18 カラギーナン 0.9 ラウリル硫酸ナトリウム 1.2 サッカリンナトリウム 0.09 パラオキシ安息香酸ブチル 0.005 香 料 1 A−AE* 0.05 水 残 量 ────────────────────── 全 量 100 * 実施例2で得たアカシア樹皮抽出物のアセトン溶出画
分Example 6 Toothpaste: Toothpaste having the following composition was prepared according to a conventional method. (Composition) Heavy part Dicalcium phosphate 42 Glycerin 18 Carrageenan 0.9 Sodium lauryl sulphate 1.2 Sodium saccharin 0.09 Butyl paraoxybenzoate 0.005 Flavor 1 A-AE * 0.05 Water remaining ─── ─────────────────── Total amount 100 * Acetone-eluted fraction of the acacia bark extract obtained in Example 2
【0043】実 施 例 7 洗 口 液:下記組成により、常法に従って洗口液を調
製した。 ( 組 成 ) 重 量 部 ラウリル硫酸ナトリウム 0.8 グリセリン 7 ソルビトール 5 エチルアルコール 15 W−AE** 0.05 L−メントール 0.05 香 料 0.04 サッカリンナトリウム 0.1 水 残 量 ────────────────────── 全 量 100 ** 実施例2で得たワットルタンニンのアセトン溶出画
分Example 7 Mouthwash: A mouthwash having the following composition was prepared according to a conventional method. (Composition) Heavy part Sodium lauryl sulfate 0.8 Glycerin 7 Sorbitol 5 Ethyl alcohol 15 W-AE ** 0.05 L-Menthol 0.05 Perfume 0.04 Saccharin sodium 0.1 Water residual amount ─── ────────────────── Total amount 100 ** Acetone elution fraction of wattle tannin obtained in Example 2
【0044】実 施 例 8 チューイングガム:下記組成により、常法に従ってチュ
ーイングガムを調製した。 ( 組 成 ) 重 量 部 ガムベース 20 炭酸カルシウム 2 ステビオサイド 0.1 Q−AE*** 0.01 乳 糖 76.89 香 料 1 ───────────────────── 全 量 100 *** 実施例2で得たケブラコタンニンのアセトン溶出画
分 以 上Example 8 Chewing gum: A chewing gum having the following composition was prepared according to a conventional method. (Composition) Weight part Gum base 20 Calcium carbonate 2 Stevioside 0.1 Q-AE *** 0.01 Lactose 76.89 Flavor 1 1 ────────────────── ──── Total amount 100 *** Acetone elution fraction of kebracotannin obtained in Example 2 and above
───────────────────────────────────────────────────── フロントページの続き (51)Int.Cl.6 識別記号 庁内整理番号 FI 技術表示箇所 C07G 17/00 A ─────────────────────────────────────────────────── ─── Continuation of the front page (51) Int.Cl. 6 Identification code Internal reference number FI technical display location C07G 17/00 A
Claims (11)
タンニンを有効成分とするグルコシルトランスフェラー
ゼ阻害剤。1. A glucosyltransferase inhibitor containing a condensed tannin derived from heartwood or bark of trees as an active ingredient.
シルトランスフェラーゼ阻害作用を有する縮合型タンニ
ンを有効成分とする抗う蝕剤。2. An anti-caries agent which is derived from heartwood or bark of a tree and contains condensed tannin having a glucosyltransferase inhibitory activity as an active ingredient.
う蝕剤。3. The anticaries agent according to claim 2, which is an oral hygiene agent.
抗う蝕剤。4. The anticaries agent according to claim 2, which is a food additive.
シルトランスフェラーゼ阻害作用を有する縮合型タンニ
ンを含有する抗う蝕性食品。5. An anti-cariogenic food containing a condensed tannin derived from heartwood or bark of a tree and having a glucosyltransferase inhibitory action.
シルトランスフェラーゼ阻害作用を有する縮合型タンニ
ンと、砂糖よりなる抗う蝕性砂糖。6. An anti-cariogenic sugar consisting of sugar and condensed tannin derived from heartwood or bark of a tree and having a glucosyltransferase inhibitory action.
抽出物を吸着カラムクロマトグラフィーに付すことを特
徴とするグルコシルトランスフェラーゼ阻害作用を有す
る抗う蝕性物質の製造方法。7. A method for producing an anticaries agent having a glucosyltransferase inhibitory activity, which comprises subjecting a heartwood or bark of a tree to solvent extraction and subjecting the extract to adsorption column chromatography.
の縮合型タンニンである請求項第7項記載の抗う蝕性物
質の製造方法。8. The weight average molecular weight is 800 to 10,000.
8. The method for producing an anticaries agent according to claim 7, which is a condensed tannin.
の縮合型タンニンである請求項第7項記載の抗う蝕性物
質の製造方法。9. A weight average molecular weight of 1,500 to 6,000.
8. The method for producing an anticaries agent according to claim 7, which is a condensed tannin.
る請求項第7項または第8項記載の抗う蝕性物質の製造
方法。10. The method for producing an anticaries agent according to claim 7, which is a condensed tannin having a degree of polymerization of 3 to 30.
る請求項第7項または第9項記載の抗う蝕性物質の製造
方法。11. The method for producing an anticaries agent according to claim 7, which is a condensed tannin having a degree of polymerization of 5 to 20.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP6062137A JPH07242555A (en) | 1994-03-08 | 1994-03-08 | Glucosyl transferase-inhibiting agent and dental caries-resistant agent and dental caries-resistant food containing the same as active ingredient |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP6062137A JPH07242555A (en) | 1994-03-08 | 1994-03-08 | Glucosyl transferase-inhibiting agent and dental caries-resistant agent and dental caries-resistant food containing the same as active ingredient |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| JPH07242555A true JPH07242555A (en) | 1995-09-19 |
Family
ID=13191404
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP6062137A Pending JPH07242555A (en) | 1994-03-08 | 1994-03-08 | Glucosyl transferase-inhibiting agent and dental caries-resistant agent and dental caries-resistant food containing the same as active ingredient |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JPH07242555A (en) |
Cited By (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2006069210A3 (en) * | 2004-12-22 | 2006-11-09 | Colgate Palmolive Co | Oral care compositions containing free-b-ring flavonoids and flavans |
| EP2108370A1 (en) | 2002-04-30 | 2009-10-14 | Unigen Pharmaceuticals, Inc. | Formulation of a mixture of free-B-ring flavonoids and flavans as a therapeutic agent |
| US8945518B2 (en) | 2002-04-30 | 2015-02-03 | Unigen, Inc. | Formulation of dual eicosanoid system and cytokine system inhibitors for use in the prevention and treatment of oral diseases and conditions |
| US9061039B2 (en) | 2002-03-01 | 2015-06-23 | Unigen, Inc. | Identification of Free-B-Ring flavonoids as potent COX-2 inhibitors |
| US9168242B2 (en) | 2002-03-22 | 2015-10-27 | Unigen, Inc. | Isolation of a dual COX-2 and 5-lipdxygenase inhibitor from Acacia |
| US9622964B2 (en) | 2003-04-04 | 2017-04-18 | Unigen, Inc. | Formulation of dual cycloxygenase (COX) and lipoxygenase (LOX) inhibitors for mammal skin care |
| WO2022054629A1 (en) * | 2020-09-10 | 2022-03-17 | 株式会社アカシアの樹 | Agent for improving and maintaining oral flora, and agent for removing dental plaque/teeth plaque and preventing tartar formation |
-
1994
- 1994-03-08 JP JP6062137A patent/JPH07242555A/en active Pending
Cited By (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US9061039B2 (en) | 2002-03-01 | 2015-06-23 | Unigen, Inc. | Identification of Free-B-Ring flavonoids as potent COX-2 inhibitors |
| US9168242B2 (en) | 2002-03-22 | 2015-10-27 | Unigen, Inc. | Isolation of a dual COX-2 and 5-lipdxygenase inhibitor from Acacia |
| EP2108370A1 (en) | 2002-04-30 | 2009-10-14 | Unigen Pharmaceuticals, Inc. | Formulation of a mixture of free-B-ring flavonoids and flavans as a therapeutic agent |
| US8945518B2 (en) | 2002-04-30 | 2015-02-03 | Unigen, Inc. | Formulation of dual eicosanoid system and cytokine system inhibitors for use in the prevention and treatment of oral diseases and conditions |
| US9370544B2 (en) | 2002-04-30 | 2016-06-21 | Unigen, Inc. | Formulation of a mixture of free-B-ring flavonoids and flavans as a therapeutic agent |
| US9655940B2 (en) | 2002-04-30 | 2017-05-23 | Unigen, Inc. | Formulation of a mixture of free-B-ring flavonoids and flavans as a therapeutic agent |
| US9849152B2 (en) | 2002-04-30 | 2017-12-26 | Unigen, Inc. | Formulation of a mixture of Free-B-ring flavonoids and flavans as a therapeutic agent |
| US9622964B2 (en) | 2003-04-04 | 2017-04-18 | Unigen, Inc. | Formulation of dual cycloxygenase (COX) and lipoxygenase (LOX) inhibitors for mammal skin care |
| WO2006069210A3 (en) * | 2004-12-22 | 2006-11-09 | Colgate Palmolive Co | Oral care compositions containing free-b-ring flavonoids and flavans |
| WO2022054629A1 (en) * | 2020-09-10 | 2022-03-17 | 株式会社アカシアの樹 | Agent for improving and maintaining oral flora, and agent for removing dental plaque/teeth plaque and preventing tartar formation |
| JP2022046082A (en) * | 2020-09-10 | 2022-03-23 | 株式会社アカシアの樹 | Oral cavity flora improving/maintaining agent, plaque/tartar removing agent, and tartar formation preventive agent |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP5283173B2 (en) | Non-cariogenic materials and anti-cariogenic agents containing rare sugars | |
| EP2620160A1 (en) | Composition for oral use | |
| EP1321148B1 (en) | Use of cyclotetrasaccharide for augmenting "active-oxygen-eliminating-activity" | |
| EP0449332A2 (en) | Glucosyltransferase inhibitors, as well as dental caries prevention methods and anticarious foods using the same | |
| JP3837172B2 (en) | Inhibitor of adhesion to periodontal tissue of Porphyromonas gingivalis containing high molecular weight polyphenol as an active ingredient | |
| JPH07242555A (en) | Glucosyl transferase-inhibiting agent and dental caries-resistant agent and dental caries-resistant food containing the same as active ingredient | |
| JPH0763294B2 (en) | Anti-cariogenic food | |
| JP3014128B2 (en) | Method for producing anti-cariogenic agent and anti-cariogenic substance | |
| Sakanaka | Green tea polyphenols for prevention of dental | |
| US20050065030A1 (en) | Reduction inhibitory agent for active oxygen eliminating activity | |
| JP2999791B2 (en) | Method for enhancing glucosyltransferase inhibitory activity | |
| WO2007020830A1 (en) | Oral composition | |
| JP3472172B2 (en) | Oral agent | |
| JPH06279303A (en) | Glucosyltransferase inhibitor | |
| JP4585066B2 (en) | Caries inhibitor, oral preparation and food and drink | |
| JPH07242556A (en) | Dental caries-resistant lavonoid polymer and glucosyl transferase-inhibiting agent and food containing the same active ingredient | |
| JP2784627B6 (en) | Anti-caries agent, anti-cariogenic food and method for producing anti-caries agent | |
| JP4495901B2 (en) | Active inhibitor for oral preparation | |
| JP2001089344A (en) | Anti-dental caries agent | |
| JP3281458B2 (en) | Glucosyltransferase inhibitors | |
| JP2002187843A (en) | Glucosyltransferase inhibitor | |
| JPH04134026A (en) | Composition for oral cavity | |
| JPH10139646A (en) | Glucosyltransferase inhibitor, oral cavity composition and food and beverage | |
| JP2001097837A (en) | Anti-caries agent | |
| JP2004284985A (en) | Caries induction inhibiting composition |